CEO Corner

  1. From Academia To Pharma CEO: Challenges And Lessons Learned

    “Looking back on my 25 years in academic medical research, I can’t think of a single learning experience that equipped me for the world of entrepreneurship, running a public company, or interacting with the capital markets.”

  2. Realizing Aspirations Through Entrepreneurship

    Being the founder and CEO of SQZ Biotech is actually Armon Sharei’s first full-time job. He warns that although people often applaud entrepreneurship, lionize its leaders, and paint it as a glamorous adventure, that isn’t really what it’s like.  

  3. Lessons Learned: The Start Of mRNA Technology Development

    Can German, American, Chinese, and other companies worldwide work together to advance the mRNA revolution and possibly launch the new “pharmacy of the world?”

  4. Considerations For Effective International Collaborations

    While there are many key aspects of a successful international collaboration across many time zones and great distance, in our experience — a collaboration between organizations based in the U.S. and Japan — there are a few essential elements.

  5. Turning The Ocean Liner: How To Advocate For A Breakthrough Treatment Paradigm

    Like an ocean liner changing course, the national discussion around “modern” healthcare has moved slowly away from volume toward health outcomes. As such, we in the industry need to be both innovators and advocates for change.

  6. CEO Corner: On Leadership

    “I’m often asked what it takes to be a successful biotech CEO, and as one of the relatively few female CEOs in our industry, what it takes to break the proverbial glass ceiling.”

  7. My Life As A Recovering VC, Zigging Where Others Zag

    Identifying and acquiring medicines would be relatively facile; however, convincing investors that the medicines were valuable was going to be a real challenge.

  8. Key Considerations For Building A Fully Integrated Biopharmaceutical Company

    There are some key points for biotech companies to consider as they begin to transform their business model to one that captures the business continuum more fully.

  9. Patients And Biopharma: Trusted Partners In Fighting Rare Diseases

    Partnerships between pharmaceutical companies and patient advocacy groups hold the key to closing the rare-disease treatment gap. Their mutual commitment to improving patient care is the foundation for collaborative innovation in rare-disease education and research.

  10. Building A Biotech with A Diversity Mindset

    A diverse workplace is critical to building a successful biotech company. When you’re leading an organization working to bring life-saving drugs to the market, every second matters, and you need to attract and retain the best talent to be successful.